PMID- 21977859 OWN - NLM STAT- MEDLINE DCOM- 20111102 LR - 20220316 IS - 0255-2922 (Print) IS - 0255-2922 (Linking) VI - 31 IP - 3 DP - 2011 Sep TI - Effects of the modified linggui zhugan decoction (see text) combined with short-term very low calorie diets on glycemic control in newly diagnosed type 2 diabetics. PG - 185-8 AB - OBJECTIVE: To evaluate the effects of the modified Linggui Zhugan Decoction (see text) combined with short-term very low calorie diets (VLCDs) on glycemic control in newly diagnosed type 2 diabetes mellitus (T2DM) patients. METHODS: A total of 20 subjects with newly diagnosed T2DM were treated with the modified Linggui Zhugan Decoction (one-month administration) combined with short-term VLCDs (5 days), and 3-months follow-up. A standard 75-g oral-glucose-tolerance test (OGTT) indexes fasting plasma glucose (FPG), post-prandial 0.5 h and 2 h plasma glucose (P0.5hPG, P2hPG), glycated hemoglobin A(1c) (GHbA(1c)), body weight, body mass index (BMI), insulin function, insulin resistance index, incidence of hypoglycemia, and the liver and renal functions were evaluated before and after treatment. Correlations of BMI with insulin function and insulin resistance were also assessed. RESULTS: After the treatment, the patients' plasma glucose decreased steadily, FPG decreased from 5.8 +/- 0.9 mmol/L at pre-treatment to 5.0 +/- 0.6 mmol/L at 3-months follow-up (P < 0.05), and P2hPG decreased from 11.7 +/- 3.8 mmol/L at pre-treatment to 6.9 +/- 0.9 mmol/L at 3-months follow-up (P < 0.01). The level of GHbA(1c) declined from (6.47 +/- 1.24)% at pre-treatment to (6.14 +/- 0.99)% at 3-months follow-up (P < 0.01). Body weight and BMI also declined significantly. Insulin resistance index was improved obviously and no event of hypoglycemia occurred. Part of the patients companied with fatty liver had a transient increase in hepatic transaminase during the treatment, but it turned to normal after the treatment. CONCLUSIONS: The modified Linggui Zhugan Decoction combined with short-term VLCDs can be safely implemented for steady glycemic control in newly diagnosed T2DM patients. FAU - Chen, Ding-Sheng AU - Chen DS AD - Department of Chinese Medicine, First Affiliated Hospital of Sun Yat-Sen University, Guangzhou, Guangdong 510080, China. FAU - Ke, Bin AU - Ke B FAU - Huang, Ying-Juan AU - Huang YJ FAU - Meng, Jun AU - Meng J FAU - Zhang, Jun-Jie AU - Zhang JJ FAU - Chen, Ze-Xiong AU - Chen ZX FAU - Michalsen, Andreas AU - Michalsen A FAU - Qin, Jian AU - Qin J LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't PL - China TA - J Tradit Chin Med JT - Journal of traditional Chinese medicine = Chung i tsa chih ying wen pan JID - 8211546 RN - 0 (Blood Glucose) RN - 0 (Plant Extracts) RN - 0 (ling-gui-zhu-gan decoction) SB - IM MH - Adult MH - Aged MH - Blood Glucose/drug effects MH - Body Mass Index MH - Body Weight/drug effects MH - *Caloric Restriction MH - Diabetes Mellitus, Type 2/*diet therapy/*drug therapy MH - Female MH - Humans MH - Male MH - Middle Aged MH - Plant Extracts/*therapeutic use EDAT- 2011/10/08 06:00 MHDA- 2011/11/04 06:00 CRDT- 2011/10/08 06:00 PHST- 2011/10/08 06:00 [entrez] PHST- 2011/10/08 06:00 [pubmed] PHST- 2011/11/04 06:00 [medline] AID - 10.1016/s0254-6272(11)60038-1 [doi] PST - ppublish SO - J Tradit Chin Med. 2011 Sep;31(3):185-8. doi: 10.1016/s0254-6272(11)60038-1.